N.I.C.E.
From Kidney Cancer Resource
Contents |
Overview
The National Institute of Clinical Excellence (N.I.C.E.)
To view the web site of N.I.C.E. Click Here
Guidance
NICE recommends sunitinib for the first-line treatment of renal cancer
N.I.C.E. Percutaneous radiofrequency ablation of renal cancer
Downloads
Appraising life-extending, end of life treatments
Pazopanib for the first line treatment of metastatic renal cell carcinoma
Pazopanib for the second line treatment of metastatic renal cell carcinoma
Renal Cell Carcinoma - letter to consultees and commentators
Announcements
Click Here for a list of all 2009 Announcements
Click Here for a list of all 2008 Announcements
Articles
Click Here for a list of all 2009 Articles
Click Here for a list of all 2008 Articles
Letters
Click Here for a list of all 2009 Letters
|
Disclaimer
Kidney Cancer Resource (KCR) is not influenced by sponsors. The information contained herein is not intended as a substitute for the advice of an appropriately qualified and licensed physician or other licensed health care provider. The information provided here is for educational and information purposes only. Early accurate Diagnosis (Dx.) saves lives. Please check with a physician if you suspect you are ill, never ignore Symptoms. To help your health care specialist make an accurate Diagnosis please keep notes of dates, times and details of your Symptoms. We are not offering medical advice nor do we consider links, individuals or articles accessed through this site to be offering medical advice.
E&OE - Errors & Omissions Excepted
As much of the information posted on this Web Site for peoples convenience is of a medical or technical nature, and may be a matter of life or death the E&OE is a Disclaimer showing that to the best of our ability information is accurate and correctly written or transcribed. Before acting on information on this site you are responsible for checking it with your relevant medical team. We can not be held responsible for any Errors & Omissions made; nor for information on links and articles provided in good faith.
